INS and gestational diabetes: Previous research has suggested that maternal characteristics including body mass index (BMI) ≥ 30 kg/m2, family history of type 2 diabetes, prior history of GDM and higher glycated haemoglobin (HbA1c) increase the likelihood of need for insulin treatment in GDM11, indicating the potential for risk-stratification of women to streamline successful GDM management.